Related Experiment Video
Updated: Aug 7, 2026
09:50
Real-time Quaking-induced Conversion Assay for Detection of CWD Prions in Fecal Material
Published on: September 29, 2017
Creutzfeldt-Jakob disease in Austria
J A Hainfellner1, K Jellinger, H Diringer
1Institute of Neurology, University of Vienna, Austria.
Journal of Neurology, Neurosurgery, and Psychiatry
|August 1, 1996
Summary
The incidence of Creutzfeldt-Jakob disease (CJD) in Austria has risen, but this is likely due to increased awareness and diagnosis, not a true increase. Data does not support a link between sporadic CJD and bovine spongiform encephalopathy (BSE).
Area of Science:
- Neurology
- Epidemiology
- Pathology
Background:
- Creutzfeldt-Jakob disease (CJD) is a rare, fatal neurodegenerative disorder.
- Understanding CJD incidence trends is crucial for public health surveillance.
Purpose of the Study:
- To analyze the incidence and characteristics of CJD in Austria between 1969 and 1995.
- To investigate potential risk factors and epidemiological trends of CJD.
Main Methods:
- Retrospective analysis of 79 neuropathologically diagnosed CJD cases in Austria.
- Examination of patient demographics, clinical data, and neuropathological findings.
- Statistical analysis of incidence rates and age distribution over time.
Main Results:
- Annual CJD incidence in Austria significantly increased, particularly after 1985.
- The rise in incidence is attributed to enhanced diagnostic awareness rather than a true increase.
- No evidence of regional clustering, familial occurrence, or recognized iatrogenic risk, except for one potential case.
- Neuropathology confirmed classic CJD changes, with anti-PrP immunocytochemistry aiding diagnosis in ambiguous cases.
- Bovine spongiform encephalopathy (BSE) has not been reported in Austria, and no link to sporadic CJD incidence was found.
Conclusions:
- The observed increase in CJD incidence in Austria is likely an artifact of improved diagnosis and reporting.
- Current data do not suggest a connection between the rise in sporadic CJD and BSE.
- Further surveillance is warranted to monitor CJD trends and potential emerging risks.
Related Concept Videos
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...